NOVARTIS AG

Verified identity

Start with the filing record

The identity and ticker come from the SEC’s official company ticker mapping. Market and editorial coverage are not inferred from that record.

Ticker: NVS
CIK: 0001114448
Exchange: NYSE
Universe updated: 2026-08-22

Open SEC filings

Market price

Latest quoteOpens Google

TickerGrove coverage

Latest on NOVARTIS AG

Companies

Novartis pelacarsen misses primary endpoint in Phase III Lp(a)HORIZON trial

Novartis said pelacarsen lowered lipoprotein(a) levels but did not meet the primary endpoint in its Phase III cardiovascular outcomes trial in patients with elevated Lp(a) and established cardiovascular disease.

Published 09-04-2026 · Novartis AG

Research foundation

Read the filing with the right frame

Company analysis

Revenue, EPS and guidance answer different earnings questions

Revenue is the top-line amount recognized from a company’s activities under its accounting policy.

Earnings reading room →

Company analysis

The three financial statements describe one business from different angles

The income statement records revenue and expenses over a period.

Company research desk →

Investing basics

Stocks, ETFs and indexes are different objects

A stock is an ownership interest in one company.

Company research desk →